Showing results (221-230 of 248) with videos related to

Sort By:
Pageof 25
Digestive Diseases and Sciences|December 1, 1993
Intragastric distribution and gastric emptying of solids and liquids in functional dyspepsia. Lack of influence of symptom subgroups and H. pylori-associated gastritisA M Scott, J E Kellow, B Shuter, et al.
Cancer Research|October 1, 1987
Isolation of amplified and overexpressed DNA sequences from adriamycin-resistant human breast cancer cellsC R Fairchild, S P Ivy, C S Kao-Shan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 1995
Transforming growth factor-beta1 circulates in normal human plasma and is unchanged in advanced metastatic breast cancerL M Wakefield, J J Letterio, T Chen, et al.
Disease Markers|September 1, 1993
Glutathione transferase GST pi in breast tumors evaluated by three techniquesR Molina, S Oesterreich, J L Zhou, et al.
Cancer Research|March 15, 1989
Expression of anionic glutathione-S-transferase and P-glycoprotein genes in human tissues and tumorsJ A Moscow, C R Fairchild, M J Madden, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1996
Phase I/II study of 72-hour infusional paclitaxel and doxorubicin with granulocyte colony-stimulating factor in patients with metastatic breast cancerJ S Fisherman, K H Cowan, M Noone, et al.
BMC Cancer|June 28, 2014
Family-specific, novel, deleterious germline variants provide a rich resource to identify genetic predispositions for BRCAx familial breast cancerHongxiu Wen, Yeong C Kim, Carrie Snyder, et al.
Annals of Surgical Oncology|April 4, 1998
Selection of local therapy after neoadjuvant chemotherapy in patients with stage IIIA,B breast cancerD N Danforth, J Zujewski, J O'Shaughnessy, et al.
Breast Cancer Research and Treatment|April 3, 2015
Two PALB2 germline mutations found in both BRCA1+ and BRCAx familial breast cancerBradley Downs, Yeong C Kim, Fengxia Xiao, et al.
Blood|October 15, 1995
A phase I study of sequential versus concurrent interleukin-3 and granulocyte-macrophage colony-stimulating factor in advanced breast cancer patients treated with FLAC (5-fluorouracil, leucovorin, doxorubicin, cyclophosphamide) chemotherapyJ A O'Shaughnessy, D J Venzon, M Gossard, et al.
Pageof 25